top of page
DONATE
About
Mission
About the Founder
PRWCC Team
Steering Committee
Members
Participating Institutions
Working Committees
Member Resources
Protocols
Foresight >
Foresight Arm A Projects
Foresight Arm B Projects
RWE 2025 >
RWE 2025 Projects (International Only)
RWE 2019 >
RWE 2019 Projects
Publications
Contact Us
< Back
Menu
Close
AYA
Bridging Therapy
carHLH
CAR Indication/Outcomes in 1st Relapse
CAR-TMA
CAR Toxicity
Commercial CAR for Lymphoma
Cytogenetics
Effect of Obesity
Effect of Peripheral Blast count at Apheresis
Expired CAR products
Extramedullary Disease
Fate post-Relapse
Fludarabine Pharmacokinetics
Germline Mutations
GVHD post-CAR
Harmonizing CAR Clinical Practice
Health Care Utilization/PHIS Financial Analysis
HSCT post-CAR (HSCT vs. Surveillance)
Immune Reconstitution and Infection
Infant ALL
InO post-CART
Machine Learning
MAP Outcomes
Mediport use as an acceptable standard for CAR infusion
Microbiome
NGS
"Pick the Winners"
Product Specifications
Prolonged Hematologic Toxicities
Race
Race, Socioeconomics and Survivorship
Research Correlatives
Real-World Ino/Blina
Second Infusions
Trisomy 21
Tumor Board
JOIN WORKING GROUP
Infant ALL
Amy Moskop
(MCW)
amoskop@mcw.edu
Erin Breese
(Cincinnati Children's)
erin.breese@cchmc.org
Erin Guest
(Children's Mercy)
eguest@cmh.edu
Lauren Pommert
(Cincinnati Children's)
Lauren.Pommert@cchmc.org
bottom of page
